Moderate

Jaundice of the Eyes - Causes, Treatment & When to See a Doctor

📅 Updated: May 2026 ⏱ 6 min read ✅ Medically reviewed

Contents

```html Jaundice of the Eyes – Causes, Diagnosis, Treatment & When to Seek Help

Jaundice of the Eyes (Scleral Icterus) – A Complete Guide

What is Jaundice of the Eyes?

Jaundice of the eyes, medically known as scleral icterus or conjunctival jaundice, refers to a yellow‑to‑orange discoloration of the whites of the eyes (the sclera). The yellow hue results from an elevated level of bilirubin—a yellow pigment produced when red blood cells break down—in the blood. When bilirubin exceeds the liver’s ability to process and excrete it, the pigment accumulates in tissues, most visibly in the skin and sclera because these areas have a relatively thin blood supply.

While the change in eye color can be subtle at first, it often becomes more pronounced as bilirubin levels rise. The condition itself is a visual clue, not a disease; it signals that something is affecting the liver’s ability to metabolize bilirubin or that bilirubin production is increased.

Common Causes

Jaundice of the eyes can stem from a wide range of medical conditions. Below are the most frequent culprits, grouped by the underlying mechanism.

  • Hepatitis (viral, alcoholic, autoimmune) – Inflammation impairs bilirubin processing.
  • Cirrhosis – Scarring reduces functional liver tissue.
  • Biliary obstruction (gallstones, pancreatic cancer, strictures) – Blocks bilirubin flow into the intestine.
  • Hemolytic disorders (sickle cell disease, thalassemia, autoimmune hemolysis) – Accelerated red‑cell breakdown raises bilirubin production.
  • Gilbert’s syndrome – A common, benign genetic variant that reduces bilirubin conjugation.
  • Drug‑induced liver injury (acetaminophen overdose, certain antibiotics, statins, herbal supplements)
  • Newborn physiological jaundice – Immature liver enzymes; usually resolves within the first two weeks of life.
  • Non‑alcoholic fatty liver disease (NAFLD) & non‑alcoholic steatohepatitis (NASH) – Accumulation of fat damages liver cells.
  • Pancreatic or liver cancers – Directly impair liver function or obstruct bile ducts.
  • Sepsis or severe infections – Can cause cholestasis (reduced bile flow) and liver dysfunction.

Associated Symptoms

Because scleral icterus reflects an underlying systemic problem, other signs often appear together. Common accompanying symptoms include:

  • Yellowing of the skin, especially on the face, neck, and palms.
  • Dark urine (tea‑colored) and pale, clay‑colored stool.
  • Itching (pruritus), particularly on the palms and soles.
  • Upper‑right abdominal pain or a feeling of fullness.
  • Fatigue, weakness, or loss of appetite.
  • Fever or chills if an infection is present.
  • Weight loss (unintentional) in chronic liver disease or cancer.
  • Swelling in the abdomen (ascites) or legs (edema) in advanced liver disease.

When to See a Doctor

The appearance of yellowing in the eyes should prompt a medical evaluation, especially if any of the following occur:

  • Yellowing spreads to the skin or becomes more intense.
  • Dark urine, pale stools, or persistent itching develop.
  • Severe abdominal pain, especially in the upper right quadrant.
  • Fever, chills, or signs of infection.
  • Confusion, drowsiness, or difficulty concentrating (possible hepatic encephalopathy).
  • Recent use of new medications, herbal products, or excess alcohol.
  • In infants: yellowing within the first 24 hours of life, or lasting more than 2 weeks.

Prompt assessment can identify life‑threatening conditions (e.g., bile duct blockage or acute liver failure) and start treatment early.

Diagnosis

Doctors combine a focused history, physical exam, and targeted tests to pinpoint the cause of scleral icterus.

History & Physical Examination

  • Medication and supplement review.
  • Alcohol consumption patterns.
  • Travel, sexual history, and exposure to hepatitis risk factors.
  • Family history of liver disease or hemolytic anemia.
  • Physical inspection of skin, sclera, abdomen (hepatomegaly, tenderness), and signs of chronic liver disease (spider angiomas, palmar erythema).

Laboratory Tests

  • Complete blood count (CBC) – Detects anemia or infection.
  • Liver panel (ALT, AST, ALP, GGT, bilirubin – total & direct, albumin, INR) – Determines pattern of liver injury.
  • Hemolysis work‑up** (LDH, haptoglobin, reticulocyte count, peripheral smear)** – Helps identify rapid red‑cell breakdown.
  • Viral hepatitis serologies (HBV, HCV, HAV, HEV).
  • Autoimmune markers (ANA, ASMA, anti‑LKM) if autoimmune hepatitis suspected.
  • Alpha‑fetoprotein (AFP) – Screening for hepatocellular carcinoma in high‑risk patients.

Imaging Studies

  • Abdominal ultrasound – First‑line for gallstones, biliary dilation, liver texture.
  • CT or MRI – Provides detailed anatomy when tumors or complex biliary disease are suspected.
  • MRCP (magnetic resonance cholangiopancreatography) – Non‑invasive view of bile ducts.
  • Endoscopic ultrasound (EUS) or ERCP – Diagnostic and therapeutic for stones or strictures.

Special Tests

  • Liver biopsy – Reserved for unclear cases or to stage chronic disease.
  • Genetic testing – For suspected Gilbert’s syndrome or other hereditary bilirubin disorders.

Treatment Options

Treatment depends on the underlying cause; the yellowing itself usually resolves once bilirubin levels normalize.

General Management

  • Stop or replace any offending medications or hepatotoxic supplements.
  • Maintain adequate hydration and a balanced diet low in saturated fat.
  • Avoid alcohol completely while the liver is recovering.
  • Phototherapy for newborns with significant bilirubin elevation (per AAP guidelines).

Cause‑Specific Therapies

  • Viral hepatitis: Antiviral agents (e.g., tenofovir, entecavir for HBV; direct‑acting antivirals for HCV).
  • Biliary obstruction: Endoscopic removal of gallstones, stenting, or surgical correction.
  • Hemolytic anemia: Treat the trigger (e.g., steroids for autoimmune hemolysis, transfusions if severe).
  • Gilbert’s syndrome: Usually requires no treatment; counsel about fasting and stress avoidance.
  • Drug‑induced injury: Discontinue the drug; N‑acetylcysteine for acetaminophen toxicity.
  • NAFLD/NASH: Weight loss (5–10% body weight), exercise, control of diabetes, and possibly pharmacologic agents (e.g., pioglitazone, vitamin E) under specialist care.
  • Cirrhosis complications: Diuretics for ascites, beta‑blockers for variceal bleeding risk, liver transplant assessment in decompensated disease.
  • Cancer: Surgery, chemotherapy, targeted therapy, or palliative care depending on stage.

Symptomatic Relief

  • Antihistamines or cholestyramine for itching.
  • Vitamin K supplementation if coagulopathy is present.
  • Ursodeoxycholic acid for certain cholestatic conditions (e.g., primary biliary cholangitis).

Prevention Tips

While not all causes are preventable, many risk factors can be modified:

  • Limit alcohol intake to ≀1 drink per day for women and ≀2 for men.
  • Maintain a healthy weight (BMI < 25) and engage in ≄150 minutes of moderate aerobic activity weekly.
  • Vaccinate against hepatitis A and B.
  • Practice safe sex and avoid sharing needles to reduce viral hepatitis risk.
  • Use medications as directed; discuss liver‑related side effects with your provider.
  • Eat a diet rich in fruits, vegetables, whole grains, and lean protein; reduce saturated fats and sugary beverages.
  • For newborns, ensure early feeding and follow pediatrician recommendations for bilirubin monitoring.

Emergency Warning Signs

If any of the following appear, seek immediate medical care (ED or urgent care). These may signal acute liver failure or a life‑threatening obstruction.

  • Sudden, severe upper‑right abdominal pain.
  • Rapidly worsening jaundice (eyes and skin turning deep orange).
  • Confusion, disorientation, or a “waxing‑moon” appearance to the face.
  • Bleeding or bruising easily (evidence of coagulopathy).
  • Vomiting blood or material that looks like coffee grounds.
  • High fever (>38.5 °C/101.5 °F) with chills.
  • Severe itching with rash or swelling of the face/lips (possible allergic reaction to medication).
  • In infants: lethargy, poor feeding, or a bulging fontanelle.

Early intervention can be lifesaving.

Sources: Mayo Clinic, CDC, NIH (National Institute of Diabetes and Digestive and Kidney Diseases), World Health Organization, Cleveland Clinic, American Academy of Pediatrics, and peer‑reviewed journals including Hepatology and Journal of Clinical Gastroenterology.

```

⚠ Medical Disclaimer

Important: The information provided on this page is for general informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

If you think you may have a medical emergency, call your doctor, go to the emergency department, or call 911 immediately.

📚 Medical References